| Literature DB >> 32516964 |
Taeyun Kim1, Jihun Kang2.
Abstract
This study aimed to evaluate the association between serum retinol and α-tocopherol levels and metabolic syndrome (MetS) using data from the Korea National Health and Nutrition Examination Survey. Of the 24,269 individuals, 5885 adults (2672 men and 3213 women) were included. The prevalence of MetS and its components according to quartiles of serum retinol and α-tocopherol levels was calculated. Multivariate linear regression model was used to calculate the number of metabolic components according to serum vitamin levels. The association between serum vitamin levels and MetS with its components was assessed using multivariate logistic regression model. The prevalence of MetS was highest in Q4 and lowest in Q1 for both vitamins, regardless of sex. A dose-dependent association between serum retinol and α-tocopherol levels and MetS was observed. After adjustment for covariates, the odds ratio (OR) for MetS in Q4 compared to Q1 was 2.351 (95% CI: 1.748-3.163, Ptrend < 0.001) in the retinol group and 2.559 (95% CI: 1.953-3.353, Ptrend < 0.001) in α-tocopherol group. Among metabolic components, hypertriglyceridemia, high fasting glucose, and high blood pressure was positively associated with serum retinol and α-tocopherol levels. In conclusion, high serum retinol and α-tocopherol levels were associated with increased risk of MetS.Entities:
Keywords: KNHANES; metabolic syndrome; retinol; α-tocopherol
Mesh:
Substances:
Year: 2020 PMID: 32516964 PMCID: PMC7352386 DOI: 10.3390/nu12061689
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Characteristics of study participants according to sex.
| Total | Men | Women | |
|---|---|---|---|
|
| 47.1 (0.3) | 46.2 (0.4) | 48.1 (0.4) |
|
| |||
| Rural | 87.1 (1.3) | 87.1 (1.4) | 87.1 (1.4) |
| Urban | 12.9 (1.3) | 12.9 (1.4) | 12.9 (1,4) |
|
| |||
| lowest | 13.1 (0.6) | 11.9 (0.8) | 14.4 (0.8) |
| lower middle | 23.5 (0.8) | 22.3 (1.0) | 24.7 (1.0) |
| higher middle | 29.9 (0.8) | 29.9 (1.1) | 29.9 (1.0) |
| highest | 33.5 (1.1) | 35.9 (1.4) | 31.0 (1.3) |
|
| |||
| Middle school or lower | 19.8 (0.7) | 14.2 (0.8) | 25.5 (1.0) |
| High school | 26.6 (0.8) | 26.1 (1.2) | 27.0 (1.0) |
| College or more | 53.6 (1.0) | 59.6 (1.3) | 47.5 (1.1) |
|
| |||
| Non-consumer | 22.4 (0.7) | 14.3 (0.9) | 30.6 (1.0) |
| <1/week | 55.9 (0.9) | 52.3 (1.3) | 59.5 (1.1) |
| ≥1/week | 21.7 (0.7) | 33.4 (1.2) | 9.8 (0.7) |
|
| |||
| Never | 60.7 (0.8) | 31.6 (1.2) | 90.2 (0.7) |
| Former | 19.7 (0.7) | 34.4 (1.2) | 4.9 (0.5) |
| Current | 19.5 (0.7) | 34.0 (1.2) | 4.9 (0.5) |
| Yes | 52.1 (0.9) | 48.6 (1.3) | 55.6 (1.1) |
| No | 47.9 (0.9) | 51.4 (1.3) | 44.4 (1.1) |
|
| |||
| <18.5 | 3.5 (0.3) | 2.5 (0.4) | 4.6 (0.5) |
| 18.5–22.9 | 39.0 (0.8) | 30.1 (1.2) | 48.1 (1.2) |
| 23–24.9 | 22.2 (0.7) | 25.5 (1.1) | 18.9 (0.8) |
| ≥25 | 35.2 (0.8) | 42.0 (1.2) | 28.3 (0.8) |
|
| |||
| Mean (SE) | 1.13 (0.0) | 1.19 (0.0) | 1.07 (0.0) |
| Median (IQR) | 0.56 (0.35–1.10) | 0.62 (0.40–1.20) | 0.50 (0.31–1.00) |
|
| |||
| WC, cm | 82.3 (0.2) | 86.2 (0.2) | 78.4 (0.2) |
| Triglyceride, mg/dL | 137.4 (2.0) | 159.6 (3.4) | 114.8 (0.4) |
| Fasting glucose, mg/dL | 100.1 (0.4) | 102.5 (0.6) | 97.8 (0.5) |
| HDL-cholesterol, mg/dL | 51.1 (0.2) | 47.4 (0.3) | 54.8 (0.3) |
| SBP, mmHg | 117.6 (0.3) | 119.9 (0.4) | 115.1 (0.4) |
| DBP, mmHg | 75.9 (0.2) | 78.3 (0.3) | 73.4 (0.2) |
|
| |||
| Median (IQR) | 0.49 (0.39–0.61) | 0.55 (0.45–0.68) | 0.44 (0.36–0.55) |
|
| |||
| Median (IQR) | 12.58 | 12.38 | 12.76 |
Data are presented as weighted percentages (standard error [SE]) for categorical variables or weighted means (SE) and medians (interquartile range [IQR].) for continuous variables, unless otherwise stated. High risk alcohol consumption was defined as 7 (alcohol 60 g) or more drinks for men and 5 (alcohol 40 g) or more drinks for women on occasion. § Adequate physical activity was defined when 1 of 3 following was satisfied: (a) at least 150–300 min per week of moderate intensity, (b) 75–150 min per week of vigorous-intensity physical activity, or (c) equivalent combination of moderate- and vigorous-intensity aerobic activity. Hs-CRP, high sensitivity C-reactive protein; WC, waist circumference; HDL, high density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood pressure.
Figure 1Estimated number of metabolic components with 95% confidence interval according to quartiles of serum retinol and α-tocopherol levels based on multivariate-adjusted linear regression analysis is shown. (A) retinol, and (B) α-tocopherol with adjustment for body mass index (BMI). (C) retinol and (D) α-tocopherol without adjustment for BMI (Ptrend < 0.001 for all analyses). Multivariate-adjusted model included age, sex, residence, household income, education, alcohol consumption, smoking status, physical activity, hs-CRP, and BMI (or not) as covariates. Hs-CRP, high sensitivity C-reactive protein; BMI, body mass index.
Prevalence and risk of metabolic syndrome according to serum retinol and α-tocopherol levels.
| Prevalence | Unadjusted | Adjusted for Age and Sex | Multivariate-Adjusted | ||||||
|---|---|---|---|---|---|---|---|---|---|
| BMI Unadjusted | Adjusted for BMI | ||||||||
| OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
| ||
| Retinol | <0.001 | <0.001 | <0.001 | <0.001 | |||||
| Q1 | 12.1 (1.1) | 1 | 1 | 1 | 1 | ||||
| Q2 | 20.9 (1.4) | 1.912 (1.468–2.491) | 1.672 (1.280–2.184) | 1.802 (1.368–2.374) | 1.703 (1.254–2.313) | ||||
| Q3 | 25.9 (1.5) | 2.526 (1.962–3.253) | 2.032 (1.561–2.645) | 2.243 (1.717–2.931) | 2.027 (1.526–2.691) | ||||
| Q4 | 33.5 (1.5) | 3.649 (2.868–4.642) | 2.651 (2.054–3.423) | 2.795 (2.129–3.670) | 2.351 (1.748–3.163) | ||||
| α-tocopherol | <0.001 | <0.001 | <0.001 | <0.001 | |||||
| Q1 | 14.5 (1.3) | 1 | 1 | 1 | 1 | ||||
| Q2 | 18.6 (1.2) | 1.338 (1.039–1.723) | 1.260 (0.969–1.639) | 1.280 (0.977–1.678) | 1.302 (0.973–1.743) | ||||
| Q3 | 26.5 (1.5) | 2.113 (1.650–2.706) | 1.848 (1.436–2.377) | 1.910 (1.479–2.466) | 1.713 (1.303–2.252) | ||||
| Q4 | 34.9 (1.6) | 3.154 (2.503–3.974) | 2.643 (2.074–3.368) | 2.690 (2.098–3.449) | 2.559 (1.953–3.353) | ||||
Serum retinol and α-tocopherol levels were categorized into quartiles; Q1 (lowest), Q2 (lower middle), Q3 (higher middle), and Q4 (highest). Multivariate-adjusted model included age, sex, residence, household income, education, alcohol consumption, smoking status, physical activity, hs-CRP, and BMI (or not) as covariates. P for trend was calculated using linear regression model considering serum vitamin levels as continuous variables. Hs-CRP, high sensitivity C-reactive protein; SE, standard error; BMI, body mass index; OR, odds ratio; CI, confidence interval.
Prevalence (prev.) and risk of components of metabolic syndrome according to serum retinol and α-tocopherol levels.
| Retinol | α-Tocopherol | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Prev. | Multivariate-Adjusted | Prev. | Multivariate-Adjusted | |||||||
| BMI Unadjusted | Adjusted for BMI | BMI Unadjusted | Adjusted for BMI | |||||||
| OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
| |||
| Abdominal obesity | <0.001 | 0.545 | 0.001 | 0.547 | ||||||
| Q1 | 19.9 (1.4) | 1 | 1 | 24.1 (1.6) | 1 | 1 | ||||
| Q2 | 26.3 (1.5) | 1.376 (1.085–1.746) | 1.111 (0.799–1.545) | 25.3 (1.5) | 1.048 (0.821–1.339) | 0.993 (0.711–1.386) | ||||
| Q3 | 29.5 (1.7) | 1.550 (1.223–1.963) | 1.161 (0.842–1.603) | 29.5 (1.5) | 1.253 (0.998–1.573) | 0.822 (0.600–1.125) | ||||
| Q4 | 34.2 (1.5) | 1.759 (1.386–2.233) | 1.125 (0.806–1.570) | 32.8 (1.5) | 1.384 (1.108–1.730) | 0.952 (0.701–1.291) | ||||
| High triglycerides | <0.001 | <0.001 | <0.001 | <0.001 | ||||||
| Q1 | 10.8 (1.1) | 1 | 1 | 13.4 (1.2) | 1 | 1 | ||||
| Q2 | 23.4 (1.6) | 2.290 (1.718–3.052) | 2.149 (1.604–2.878) | 21.0 (1.5) | 1.948 (1.487–2.551) | 1.897 (1.444–2.492) | ||||
| Q3 | 31.7 (1.6) | 3.276 (2.495–4.302) | 2.980 (2.260–3.929) | 33.0 (1.6) | 3.941 (3.033–5.122) | 3.622 (2.780–4.717) | ||||
| Q4 | 47.3 (1.6) | 5.376 (4.054–7.131) | 4.718 (3.538–6.293) | 49.3 (1.6) | 8.149 (6.225–10.668) | 7.633 (5.841–9.975) | ||||
| Low HDL-cholesterol | 0.494 | 0.465 | 0.896 | 0.213 | ||||||
| Q1 | 31.7 (1.6) | 1 | 1 | 31.3 (1.7) | 1 | 1 | ||||
| Q2 | 32.2 (1.7) | 1.074 (0.867–1.330) | 1.010 (0.811–1.258) | 28.2 (1.5) | 0.782 (0.629–0.972) | 0.748 (0.596–0.938) | ||||
| Q3 | 34.0 (1.5) | 1.232 (0.990–1.533) | 1.102 (0.878–1.383) | 31.7 (1.6) | 0.841 (0.683–1.037) | 0.762 (0.614–0.944) | ||||
| Q4 | 28.8 (1.5) | 1.053 (0.846–1.310) | 0.898 (0.715–1.126) | 34.5 (1.6) | 0.935 (0.755–1.158) | 0.832 (0.668–1.037) | ||||
| High fasting glucose | <0.001 | <0.001 | <0.001 | 0.006 | ||||||
| Q1 | 19.5 (1.3) | 1 | 1 | 26.0 (1.6) | 1 | 1 | ||||
| Q2 | 28.7 (1.5) | 1.438 (1.143–1.809) | 1.350 (1.067–1.708) | 29.0 (1.4) | 1.064 (0.838–1.352) | 1.031 (0.805–1.320) | ||||
| Q3 | 35.2 (1.7) | 1.755 (1.374–2.240) | 1.569 (1.221–2.016) | 35.8 (1.7) | 1.312 (1.028–1.673) | 1.168 (0.911–1.497) | ||||
| Q4 | 45.0 (1.7) | 2.233 (1.758–2.836) | 1.906 (1.489–2.439) | 41.2 (1.6) | 1.521 (1.198–1.930) | 1.353 (1.061–1.726) | ||||
| High blood pressure | <0.001 | 0.007 | <0.001 | <0.001 | ||||||
| Q1 | 18.4 (1.4) | 1 | 1 | 21.9 (1.5) | 1 | 1 | ||||
| Q2 | 25.8 (1.4) | 1.227 (0.952–1.583) | 1.162 (0.895–1.508) | 25.9 (1.4) | 1.149 (0.901–1.466) | 1.137 (0.892–1.450) | ||||
| Q3 | 30.8 (1.6) | 1.381 (1.067–1.787) | 1.272 (0.977–1.655) | 32.9 (1.6) | 1.468 (1.156–1.863) | 1.368 (1.076–1.739) | ||||
| Q4 | 39.5 (1.6) | 1.594 (1.233–2.061) | 1.420 (1.092–1.847) | 36.6 (.1.6) | 1.568 (1.244–1.976) | 1.460 (1.154–1.846) | ||||
Serum retinol and α-tocopherol levels were categorized into quartiles; Q1 (lowest), Q2 (lower middle), Q3 (higher middle), and Q4 (highest). Multivariate-adjusted model included age, sex, residence, household income, education, alcohol consumption, smoking status, physical activity, hs-CRP, and BMI (or not) as covariates. P for trend was calculated using linear regression model considering serum vitamin levels as continuous variables. HDL, high density lipoprotein; hs-CRP, high sensitivity C-reactive protein; SE, standard error; BMI, body mass index; OR, odds ratio; CI, confidence interval.